Patient demographic characteristics
| . | Treatment arm, no. (%) . | |
|---|---|---|
| A . | B . | |
| Total n (%) | 93 (48) | 100 (52) |
| Sex | ||
| Male | 46 (49) | 53 (53) |
| Female | 46 (51) | 47 (47) |
| Age at diagnosis | ||
| Median, y | 1 | 1 |
| Minimum, mo | 1 | 1 |
| Maximum, y | 17.5 | 16.5 |
| Younger than 2 y | 81 (87) | 84 (84) |
| 2 y or older | 12 (13) | 16 (16) |
| Risk organ involvement | 68 (73) | 78 (78) |
| Liver | 38 (41) | 45 (45) |
| Lungs | 36 (39) | 21 (21) |
| Hematopoietic system | 31 (33) | 40 (40) |
| Spleen | 31 (33) | 36 (36) |
| . | Treatment arm, no. (%) . | |
|---|---|---|
| A . | B . | |
| Total n (%) | 93 (48) | 100 (52) |
| Sex | ||
| Male | 46 (49) | 53 (53) |
| Female | 46 (51) | 47 (47) |
| Age at diagnosis | ||
| Median, y | 1 | 1 |
| Minimum, mo | 1 | 1 |
| Maximum, y | 17.5 | 16.5 |
| Younger than 2 y | 81 (87) | 84 (84) |
| 2 y or older | 12 (13) | 16 (16) |
| Risk organ involvement | 68 (73) | 78 (78) |
| Liver | 38 (41) | 45 (45) |
| Lungs | 36 (39) | 21 (21) |
| Hematopoietic system | 31 (33) | 40 (40) |
| Spleen | 31 (33) | 36 (36) |
Data are number (%) unless otherwise indicated.